Literature DB >> 29295124

Acute Coronary Syndrome Risk Prediction Based on GRACE Risk Score.

Danqing Hu1, Zhengxing Huang1, Tak-Ming Chan2, Wei Dong3, Xudong Lu1, Huilong Duan1.   

Abstract

Clinical risk prediction of acute coronary syndrome (ACS) plays a critical role for clinical decision support, treatment management and quality of care assessment in ACS patients. Admission records contain a wealth of patient information in the early stages of hospitalization, which offers the opportunity to support the ACS risk prediction in a proactive manner. However, ACS patient risks aren't recorded in hospital admission records, thus impeding the construction of supervised risk prediction models. In our study, we propose a novel approach for ACS risk prediction, which employs a well-known ACS risk prediction model (GRACE) as the benchmark methods to stratify patient risks, and then utilizes a state-of-the-art supervised machine learning algorithm to establish our risk prediction models. The experiment was conducted with a collection of 3,643 ACS patient samples from a Chinese hospital. Our best model achieved 0.616 accuracy for risk prediction, which indicates our learned model can achieve a better performance than the benchmark GRACE model and can obtain significant improvement by mixing up patient samples that were manually labeled risks.

Entities:  

Keywords:  Acute Coronary Syndrome; Risk Assessment; Supervised Machine Learning

Mesh:

Year:  2017        PMID: 29295124

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.

Authors:  Chengji Wang; Yu Kong; Yuanyuan Ding; Jingzhi Sun; Tao Chen
Journal:  Med Sci Monit       Date:  2019-12-13

2.  Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study.

Authors:  Wutang Zhang; Yongmei Kong; Lizhi Wang; Lizhong Song; Lijuan Tan; Xiaobo Xue
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.